Recent research suggests that select athletes with cardiovascular abnormalities may be able to safely participate in competitive sports after shared decision-making with their clinicians about potential risks, according to a joint scientific statement published today in the journal Circulation and simultaneously in JACC.
FDA approves Romvimza for tenosynovial giant cell tumor (TGCT)
The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue that lines the joints.
New toolkit empowers health care providers with evidence-based strategies for childhood obesity prevention and treatment
Greaux Healthy—a public service initiative powered by Pennington Biomedical Research Center, in partnership with the State of Louisiana—has released the Childhood Obesity Prevention, Evaluation and Treatment Toolkit, a comprehensive resource designed to equip health care providers with practical, evidence-based guidance for preventing, evaluating, and treating childhood obesity and its related comorbidities.
New findings on tumor reduction and survival outcomes in advanced renal cell carcinoma
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in Renal Cell Carcinoma) study underscore the critical role of tumor size reduction in improving survival outcomes for patients with advanced renal cell carcinoma (aRCC).
Research indicates fitness apps fuel disordered eating
With New Year resolutions in full swing and health tracking apps at our fingertips, new research reveals concerning links between health and fitness apps and disordered eating, body image concerns and excessive exercise.
Almost 90% of people would agree to genetic testing to tailor medication use, survey finds
New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects. The study is published in the QJM: An International Journal of Medicine.
Daily cannabis use linked to public health burden
A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called cannabinoid hyperemesis syndrome. Researchers at the George Washington University say the condition occurs in people who are long-term regular consumers of cannabis and causes nausea, uncontrollable vomiting and excruciating pain in a cyclical pattern that often leads to repeated trips to the hospital.
Fortifying bouillon could reduce malnutrition in West Africa
In September, the Nigerian government made an important change to its food fortification program to date—a set of standards outlining that voluntarily fortified bouillon cubes must contain minimum amounts of four micronutrients: iron, zinc, folic acid and vitamin B12. While some foods are already fortified in the country, the dehydrated seasoning blocks, consumed in virtually all Nigerian households, may prove to be the ideal vessel for some vitamins and minerals.
Investigators say YoMap’s reported online harrassment case against his family.
TWO investigators testified how acclaimed artiste and music producer Elton Mulenga alias YoMap’s reported that his family was being issued with threats by businessman and blogger Elias Musyani via Facebook. The witnesses said Mr Mulenga complained that Mr Musyani uttered defamatory words against his wife Kidist Kifle, who he reffered to as prostitute. This is […]
The post Investigators say YoMap’s reported online harrassment case against his family. first appeared on Mwebantu.
Platform trials streamline ALS therapy evaluation by rapidly ruling out ineffective drugs
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate potential treatments for amyotrophic lateral sclerosis (ALS), with results published in various JAMA journals.